Take the path from ideas to life-altering drugs

Developing a new drug means finding white space in the market. The journey from ideas to patent is guided by the latest knowledge and technology. Access to the latest interdisciplinary research is critical for improving drug discovery insights and increasing drug development success rates.

How we help
With unprecedented coverage of research across all disciplines, books, journals, conference proceedings and patents, Scopus enables researchers to search, analyze and validate findings with more confidence to drive drug discovery and development and increase productivity.

Scopus helps researchers and other R&D professionals to:

  • Accelerate the drug development and discovery process, getting up to speed quickly on past research findings
  • Limit R&D dead-ends and failures with decisions based on extensive knowledge and accurate validation
  • Spot global and regional trends in R&D
  • Benchmark against competitors
  • Find the right experts and key opinion leaders

A pre-clinical study is fast-tracked through expert collaboration

Featured customer story

A pre-clinical study is fast-tracked through expert collaboration

A pharmaceutical R&D expert describes how Scopus helped her strategic unit in a midmarket pharmaceutical company connect with key experts. That partnership powered her efforts to move compounds through to the preclinical phase quicker and ahead of competitors.

Read more
More customer stories

Ideas and insights for industry professionals

Precision Medicine in R&D

Precision Medicine in R&D - Industry Insights |Elsevier R&D Solutions

Drug makers are turning their focus from developing blockbuster drugs to making advances in precision medicine treatments. But what will they need to do to succeed?
Read the white paper

The Era of Immunotherapeutics

The Era of Immunotherapeutics - Industry Insights |Elsevier R&D Solutions

By boosting anti-cancer response using a patient’s own immune system, immunotherapeutics are showing incredible promise in offering more effective treatments with fewer side effects for cancer patients.
Read the white paper